ATE445647T1 - Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafür - Google Patents
Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafürInfo
- Publication number
- ATE445647T1 ATE445647T1 AT04805265T AT04805265T ATE445647T1 AT E445647 T1 ATE445647 T1 AT E445647T1 AT 04805265 T AT04805265 T AT 04805265T AT 04805265 T AT04805265 T AT 04805265T AT E445647 T1 ATE445647 T1 AT E445647T1
- Authority
- AT
- Austria
- Prior art keywords
- human
- immunoglobulin
- transgenic
- heavy chain
- constant region
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title abstract 2
- 102000018358 immunoglobulin Human genes 0.000 title abstract 2
- 230000009261 transgenic effect Effects 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 3
- 108700024394 Exon Proteins 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 108700019146 Transgenes Proteins 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000002308 embryonic cell Anatomy 0.000 abstract 1
- 230000006801 homologous recombination Effects 0.000 abstract 1
- 238000002744 homologous recombination Methods 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0312502A FR2861255B1 (fr) | 2003-10-24 | 2003-10-24 | Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications. |
PCT/FR2004/002701 WO2005047333A1 (fr) | 2003-10-24 | 2004-10-21 | Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE445647T1 true ATE445647T1 (de) | 2009-10-15 |
Family
ID=34400790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04805265T ATE445647T1 (de) | 2003-10-24 | 2004-10-21 | Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafür |
Country Status (8)
Country | Link |
---|---|
US (1) | US8629317B2 (de) |
EP (1) | EP1680449B1 (de) |
JP (1) | JP2008501303A (de) |
AT (1) | ATE445647T1 (de) |
DE (1) | DE602004023637D1 (de) |
ES (1) | ES2335018T3 (de) |
FR (1) | FR2861255B1 (de) |
WO (1) | WO2005047333A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926438B1 (fr) * | 2008-01-22 | 2013-01-11 | Univ Limoges | Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe g et ses applications |
LT2346994T (lt) | 2008-09-30 | 2022-03-10 | Ablexis, Llc | Knock-in pelė, skirta chimerinių antikūnų gamybai |
BRPI1005959A2 (pt) * | 2009-02-27 | 2015-08-25 | Genentech Inc | "vetor de direcionamento, método de produção de uma célula haste embriônica alterada in vitro, animal não humano, mamífero não humano, modelo animal, modelo animal/mamífero não humano, método de teste de terapia de alergia, linhagem celular, célula isolada de um modelo animal, processo de elaboração de um modelo animal não humano e camundongo recombinante |
ES2595376T3 (es) * | 2009-12-10 | 2016-12-29 | Regeneron Pharmaceuticals, Inc. | Ratones que producen anticuerpos de cadena pesada |
LT3248462T (lt) | 2010-03-31 | 2024-05-27 | Ablexis, Llc | Pelių genų inžinerija, skirta chimerinių antikūnų gamybai |
KR102434557B1 (ko) | 2010-08-02 | 2022-08-23 | 리제너론 파아마슈티컬스, 인크. | Vl 도메인을 포함하는 결합 단백질을 생성하는 마우스 |
EP2820947A1 (de) * | 2013-07-05 | 2015-01-07 | B Cell Design | Transgenes nichtmenschliches Säugetier zur Herstellung chimärer humaner Immunglobulin-E-Antikörper |
EP2905031A1 (de) | 2014-02-10 | 2015-08-12 | B Cell Design | Neues, nicht-HIV-Impfstoff-Antigen aus der vaginalen Mikrobiota zur Induzierung einer mukosalen, neutralisierenden, schützenden Antikörperreaktion gegen eine HIV-Infektion |
KR20210088756A (ko) | 2014-03-21 | 2021-07-14 | 리제너론 파마슈티칼스 인코포레이티드 | 단일 도메인 결합 단백질을 생산하는 비-인간 동물 |
US20150266976A1 (en) | 2014-03-21 | 2015-09-24 | Regeneron Pharmaceuticals, Inc. | Vl antigen binding proteins exhibiting distinct binding characteristics |
KR20230155600A (ko) | 2014-04-03 | 2023-11-10 | 아이쥐엠 바이오사이언스 인코포레이티드 | 변형된 j-사슬 |
ES2874558T3 (es) | 2015-03-04 | 2021-11-05 | Igm Biosciences Inc | Moléculas de unión a CD20 y usos de las mismas |
JP2018508224A (ja) | 2015-03-19 | 2018-03-29 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | 抗原を結合する軽鎖可変領域を選択する非ヒト動物 |
AU2016329197B2 (en) | 2015-09-30 | 2021-01-21 | Igm Biosciences, Inc. | Binding molecules with modified J-chain |
WO2017059387A1 (en) | 2015-09-30 | 2017-04-06 | Igm Biosciences, Inc. | Binding molecules with modified j-chain |
EP3398967A1 (de) | 2017-05-04 | 2018-11-07 | B Cell Design | Antikörper gegen karzinoembryonisches antigen zur krebstherapie und -diagnose |
CN108486126A (zh) * | 2018-03-27 | 2018-09-04 | 重庆金迈博生物科技有限公司 | 一种核酸分子及其在人源化抗体中的应用 |
WO2020053865A1 (en) * | 2018-09-13 | 2020-03-19 | Ramot At Tel-Aviv University Ltd. | Genetic engneering of b cell receptors and uses thereof in antigen-induced antibody secretion |
US20220340926A1 (en) * | 2019-05-27 | 2022-10-27 | Transgenic Inc. | Exon-humanized mouse |
CN115197942A (zh) * | 2021-04-09 | 2022-10-18 | 北京大学第一医院 | 一种可表达人源IgA1蛋白的鼠模型及其构建方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8823869D0 (en) * | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
JPH08140528A (ja) * | 1993-12-03 | 1996-06-04 | Genpharm Internatl Inc | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
US5714352A (en) * | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
US6833268B1 (en) * | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
JP2005510201A (ja) * | 2001-01-26 | 2005-04-21 | アブジェニックス インコーポレイテッド | Hiv−1に対する中和ヒトモノクローナル抗体、それらの産生および使用 |
-
2003
- 2003-10-24 FR FR0312502A patent/FR2861255B1/fr not_active Expired - Lifetime
-
2004
- 2004-10-21 WO PCT/FR2004/002701 patent/WO2005047333A1/fr active Application Filing
- 2004-10-21 DE DE602004023637T patent/DE602004023637D1/de not_active Expired - Lifetime
- 2004-10-21 ES ES04805265T patent/ES2335018T3/es not_active Expired - Lifetime
- 2004-10-21 AT AT04805265T patent/ATE445647T1/de not_active IP Right Cessation
- 2004-10-21 US US10/577,061 patent/US8629317B2/en active Active
- 2004-10-21 JP JP2006536126A patent/JP2008501303A/ja active Pending
- 2004-10-21 EP EP04805265A patent/EP1680449B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1680449A1 (de) | 2006-07-19 |
DE602004023637D1 (de) | 2009-11-26 |
WO2005047333A1 (fr) | 2005-05-26 |
US20070248601A1 (en) | 2007-10-25 |
FR2861255B1 (fr) | 2006-02-17 |
EP1680449B1 (de) | 2009-10-14 |
ES2335018T3 (es) | 2010-03-18 |
US8629317B2 (en) | 2014-01-14 |
FR2861255A1 (fr) | 2005-04-29 |
JP2008501303A (ja) | 2008-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE445647T1 (de) | Nicht-humaner säuger, welcher transgen ist für die konstante region der schweren kette vom humanem klasse a immunoglobulin und verwendung dafür | |
US20230189772A1 (en) | Humanized il-15 animals | |
EP1597382B1 (de) | Gen-modifizierte nicht-menschliche säuger und zellen | |
ES2641920T3 (es) | Ingeniería genética de animales no humanos para la producción de anticuerpos quiméricos | |
CA2376299A1 (en) | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions | |
BR122020013427B1 (pt) | Método para fazer um camundongo, uma célula ou tecido derivado de um camundongo e um hibridoma | |
AU2005213965A1 (en) | Gene disruptions, compositions and methods relating thereto | |
AU2005224992B2 (en) | Transgenic model for Alzheimer's disease | |
MX2021014893A (es) | Animales no humanos que tienen un repertorio de cadena ligera lambda limitado expresado a partir del locus kappa y usos de estos. | |
JP3765574B2 (ja) | 逆向き反復配列を含む組み換え遺伝子及びその利用 | |
KR20210020018A (ko) | 진행성 골화성 섬유이형성증의 설치류 모델 | |
KR20150126867A (ko) | 조건적 Acvr1 돌연변이체 대립형질을 갖는 설치류 | |
DE60118913T2 (de) | Transgenes tiermodell für neurodegenerative erkrankungen | |
JP2004523234A5 (de) | ||
US20060265772A1 (en) | Histamine hyperproductive animal | |
WO2023046201A1 (en) | Genetically modified non-human animal with human or chimeric genes | |
CN114606270A (zh) | 一种Mia3条件性基因敲除小鼠模型的构建方法 | |
JP2004049083A (ja) | パピローマウイルスベクターを用いたRNAi表現型を有する非ヒト哺乳動物の作製方法 | |
JPWO2021216505A5 (de) | ||
PT1255437E (pt) | Feromonas calmantes de aves, para diminuir o stress, anxiedade e agressividade |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |